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Summary
Introduction. Psoriasis is a chronic inflammatory skin disease with various biochemical, immunologic and vascular changes, and a 
vague relationship to nervous system function. Skin defends the body by rapidly setting an innate immune response and providing a 
swift first–line defense against infection or injury. Hundreds of naturally occurring antimicrobial peptides have been discovered and 
it has been shown that psoriatic epidermis expresses high levels of host defense proteins.  
Aim of the Study. To evaluate human antimicrobial peptides in correlation with inflammation level in skin biopsy material of psoriatic 
lesions.
Materials and methods. We evaluated 9 psoriasis patients and 1 healthy volunteer. Skin biopsies were obtained from using the 
routine punch biopsy method. All tissue specimens were stained with hematoxylin and eosin and by immunochemistry for human 
β defensin 2, PGP 9.5, MMP2. The intensity of immunostaining was graded semiquantitatively. For apoptosis evaluation, we used 
TUNEL method.  
Results. We found a distinct inflammatory cell infiltration with diffusive character in subepithelial layer, epithelium and hair 
follicle outer epithelial sheath. Defensin–containing cell number, PGP 9.5–containing nerve fibers and number of MMP2 positive 
macrophages, fibroblasts and epitheliocytes varied from few to abundant in the visual field. Apoptosis affected epithelial cells, 
connective tissue cells and inflammatory cells focally.
Conclusions. Histological findings vary from marked inflammatory cell infiltration to granulation tissue. Psoriatic lesions of 
patients with no previous active psoriasis treatment feature marked activation of defensin, matrix metalloproteinase, apoptosis 
and neuropeptides–containing innervation. In skin of psoriasis patients with long–term ineffective treatment psoriatic lesions show 
abundance of positive structures of defensin, matrix metalloproteinase and neuropeptides–containing innervation. Close correlation 
between expression of defensin–containing cells, apoptotic cells, and inflammation in the skin was found suggesting about possible 
stimulation of AMPs and apoptosis by specific inflammation. 
Key words: antimicrobial peptides, human keratinocytes, immunity, psoriasis.
Abbreviations: AMPs – Antimicrobial peptides; HBD–2 – Human beta defensin 2; HNP – Human neuthrophil peptides; IMH – 
Immunohistochemical method; MMP2 – Matrix metalloproteinase 2; PGP 9.5 – Protein gene product 9.5; PKC – Protein kinase C.  
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INTRODUCTION
Psoriasis is a chronic inflammatory skin disease, with a 
strong genetic basis, characterized by complex alterations 
in epidermal growth and differentiation and multiple 
biochemical, immunologic and vascular abnormalities, 
and a poorly understood relationship to nervous system 
function (10).  
The skin is situated at the interface between an 
organism’s internal milieu and an external environment 
characterized by constant attack with potential 
microbial pathogens. Now it is evident that a major 
role of the skin is to defend the body by rapidly setting 
an innate immune response and providing a swift 
first–line defense against infection or injury. Both 
resident and infiltrating cells in the skin synthesize 
and secrete small peptides that demonstrate broad–
spectrum antimicrobial activity against bacteria, fungi, 
and viruses. Antimicrobial peptides (AMPs) also act 
as multifunctional immune effectors by stimulating 
cytokine and chemokine production, angiogenesis, 
wound healing, cell proliferation, chemotaxis, immune 
induction, and protease–antiprotease balance (3, 5).  
Hundreds of naturally occurring antimicrobial peptides 
have been discovered based on their potency to inhibit 
the growth of microbial pathogens. There are two major 
families of AMPs – defensins and cathelicidins. Current 
evidence shows that both above mentioned families of 
AMPs act as natural antibiotics and as well as signaling 
molecules that activate host cell processes involved in 
immune defense and tissue repair. Modifications in the 
expression pattern of AMPs have been associated with a 
variety of pathological processes (2).
Antimicrobial peptides are predominantly small cationic 
polypeptides that are classified together due to their 
capacity to inhibit microbes. Defensins and cathelicidins 
comprise the major families of antimicrobial peptides 
in the skin, although other cutaneous peptides, such as 
proteinase inhibitors, chemokines, and neuropeptides, 
also demonstrate antimicrobial activity. Together, these 
multifunctional antimicrobial peptides play an important 
role in skin immune defense and pathogenesis of disease 
(4).
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Antimicrobial peptides are produced by leukocytes 
and epithelial cells not only in skin, but also in 
the gastrointestinal and genitourinary tracts, 
tracheobronchial tree. They include defensins, 
cathelicidin, histatins, cathepsin G, azurocidin, chymase, 
eosinophil derived neurotoxin, high mobility group 1 
nuclear proteins, lactoferrin (17). 
The defensins can be classified into two subfamilies (α– 
and β–defensins) based on their tertiary structure. The 
alfa defensins also are known as the human neuthrophil 
peptides (HNP 1–3) and are largely stored in the granules 
of neuthrophils and macrophages. There are also many 
β defensins (HBD). HBD1 is expressed constitutively by 
keratinocytes, HBD2–4 on the other hand is inducible 
and produced by keratinocytes and epithelial cells in 
response to proinflammatory stimuli. Evaluation of the 
human genome suggests that there may be an additional 
25 β defensins that have not yet been identified (17). 
Several studies compare psoriasis and atopic dermatitis 
as the two most common chronic skin diseases. Patients 
with atopic dermatitis, but not psoriasis, suffer from 
frequent skin infections. The expression of innate 
immune response genes and antimicrobial peptides 
has been found to be decreased in atopic dermatitis, as 
compared with psoriasis, despite that both skin diseases 
are characterized by defective skin barriers. Psoriatic 
epidermis expresses high levels of host defense proteins 
compared with atopic dermatitis epidermis (13, 14, 16). 
Psoriatic–scale extracts have been identified as a unique 
source of human–inducible antibiotic peptides and 
proteins, among them psoriasin, HBD–2, and RNase 7, 
as by far, the quantitatively dominating antimicrobial 
peptides. These peptides and proteins can also be found 
at much lower levels in healthy skin, where they are 
expressed focally (11).
Other researches consider protein kinase C (PKC) 
inhibitor AEB071 and type I interferon as potential 
therapeutic options or targets for psoriasis (20, 22).
Great involvement in the pathogenesis of psoriasis have 
demonstrated neuropeptides – increased findings of 
antibodies to vasoactive intestinal polypeptide, substance 
P, calcitonin gene–related peptide, neuropeptide Y, and 
the general neuronal marker protein gene product 9.5 
have been found. These substances can not only be 
released by nerve endings, but may also be synthesized 
directly in the skin and released from various dermal 
cells (1, 18).
Despite to all above mentioned data, still there is a lack 
of knowledge about distribution and relative appearance 
in antimicrobial peptides in the skin of patients with 
psoriasis, especially in different stages of disease. Thus, 
the aim of this study was to research of appearance 
in skin antimicrobial peptides in correlation with 
inflammation level in ontogenetic aspects of patients 
with psoriasis.
AIM OF THE STUDY
The aim of the study was to evaluate human 
antimicrobial peptides in correlation with inflammation 
level in skin biopsy material of psoriatic lesions.
MATERIALS AND METHODS
Patients. All psoriasis patients were diagnosed by a 
dermatologist. Skin biopsies were obtained from the 
skin lesions of nine different psoriasis patients using 
the routine punch biopsy method and one healthy 
volunteer using excision. All patients were off topical 
and systemic medication for more than 4 weeks before 
their skin biopsy was taken. 
Patient selection criteria were created to achieve as 
much as possible accurate results with less affecting side 
factors.
Inclusion criteria were developed in accordance to 
previously realized researches, as well as to knowledge 
of immunological changes in skin due to exposure to 
sun and treatment with topical vitamin D analogue 
calcipotriol (13, 16, 24): patient 18 and older; patient 
has psoriasis symptoms for at least 6 weeks, preferable 
diagnosed for the first time; visible characteristic psoriatic 
eruptions in typical localization sites; patient hasn’t 
received any previous treatment for at least a month; 
skin is not fiercely tanned; patient hasn’t received any 
antibiotic treatment during last month.
Exclusion criteria were following: patient has received 
psoriasis or antibiotic treatment during last month; other 
confirmed skin diseases – such as various origin urticaria, 
eczema, atopic dermatitis, folliculitis; much tanned skin; 
other systemic diseases – such as inflammatory bowel 
diseases, acute liver diseases, diabetes mellitus, plodding 
cardiovascular diseases, autoimmune diseases, and 
oncology.
As a result we selected nine psoriasis patients – seven 
male and two female in age group from 25 to 68, average 
age 44,7; volunteer – 33 years old female.
The study was approved by the Ethical Committee at 
Riga Stradins University, permit issued on September 
10, 2009. 
Methods 
1) Skin biopsies were fixed in Stefanini’s solution, 
dehydrated and embedded in paraffin. Four micrometer 
thick sections were prepared from each tissue specimen 
and stained routinely with hematoxylin and eosin 
(Lillie, 1969). 
2) Immunohistochemical method (IMH). Human beta 
defensin 2 (cat No AF 2758, LOT VJU015051, obtained 
from goat, 1:100 dilution, R&D Systems, Germany), 
PGP 9.5 (code Z5116, obtained from rabbit, 1:600 
dilution, DakoCytomation, Denmark) and MMP2 (cat 
No AF902, LOT DUB034081, obtained from goat, 1:100 
dilution, R&D Systems, Germany) were used by biotin – 
streptavidin IMH (Hsu et al., 1981).
3) For TUNEL method we used In situ Cell Death 
Detection, POD cat No 1684817 (Roche Diagnostics, 
Negoescu et al., 1998). 
4) For visual illustration of our findings we used Leica 
DC 300F digital camera and image processing and 
analysis software Image Pro Plus.
The intensity of immunostaining was graded 
semiquantitatively and few positive structures in the 
visual field were labelled with +, moderate number 
of positive structures in the visual field was labeled 
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with ++, numerous positive structures in the visual 
field were labeled with +++, and abundance of positive 
structures in the visual field was marked with ++++.
Results of TUNEL method were obtained by counting 
apoptosis positive cells in three unintentionally chosen 
fields of vision. The mean ± SD was calculated for each 
specimen.        
RESULTS
Intraepithelial lymphocytes, a distinct inflammatory 
cell infiltration in subepithelial layer as well as the 
presence of epithelioid cells and macrophages were 
detected in all patients (Fig. 1 – 2). Similar inflammatory 
cell infiltration was detected also in hair follicle outer 
epithelial sheath and in epithelium. Arteriole sclerosis 
and sweat gland cell vacuolization were established (Fig. 
3). Inflammatory infiltration showed diffusive character. 
Patient with long–drawn psoriasis demonstrated 
granulations in the tissue. Also vacuolization in epithelial 
layer and Munro’s microabscess were observed focally.
Defensin–containing cell number varied from few 
to abundant (Fig. 4 – 6). Pronounced correlation 
was observed between defensin–containing cells 
and apoptosis findings. Explicit increase of defensin–
containing cells and apoptosis was noticed in sites of 
active inflammation; meanwhile in areas of granulation 
both findings were negative.   
PGP 9.5–containing nerve fibers were found in all 
specimens and their number varied from few to 
abundant (Fig. 7). Fine PGP 9.5 positive nerves occupied 
subepithelial area and reached the epithelium. 
Number of MMP2 positive macrophages, fibroblasts and 
epitheliocytes varied from few to abundant mainly in 
the subepithelium (Fig. 8). The results are summarized 
in Table 1.
Marked apoptosis affected epithelial cells, connective 
tissue cells and inflammatory cells focally (Fig. 9 – 10). 
However, there was also an interesting observation 
found in patient with very long psoriasis anamnesis and 
previous unsuccessful treatment, when in the region 
of granulation tissue number of apoptotic cells notably 
decreased (Table 2).
DISCUSSION
Antimicrobial peptides represent efficient innate defense 
mechanism which protects interfaces from infection 
with pathogenic microorganisms. In human skin AMPs 
mainly are produced by keratinocytes, neutrophils, and 
sweat glands and are either expressed constantly or 
after an inflammatory trigger. In several human diseases 
there is an inverse correlation between severity of the 
disease and the level of AMPs production. Decreased 
levels of AMPs are associated with burns and chronic 
wounds. In contrast, overexpression of AMPs can lead 
to increased protection against skin infections as seen in 
patients with psoriasis and rosacea, inflammatory skin–
diseases which rarely result in superinfection. Increased 
levels of AMPs are often found in inflamed or infected 
skin areas in patients with acne vulgaris indicating a role 
of these peptides in the protection of infection. These 
data indicate that AMPs have a therapeutical potential 
as topical agents in several skin diseases (6, 19).    
Antimicrobial peptides have maintained broad–
spectrum antimicrobial activity and resisted most 
microbial strategies, which suggests that antimicrobial 
peptides may be strong alternatives to current antibiotic 
regimens in select disease situations (15). 
The number of human beta defensin 2 positive 
structures in our study varied very broadly. Abundance 
of positive structures was found in specimens of two 
patients, both with a very long anamnesis of the disease 
(15 and 44 years) and previous unsatisfactory outcome 
of the treatment. Meanwhile, the number of positive 
structures found in specimen of volunteer and other 
patients was moderate to numerous. Increased number 
of HBD–2 in psoriatic lesions as well as increased serum 
level compared to healthy controls earlier has been 
shown and is tightly related also with the macroscopical 
clinical activity (12).   
In the present study, the number of PGP 9.5 positive 
nerve fibers was found at an average amount of 
numerous positive structures in the visual field. Likewise 
abundance of positive structures was found in specimen 
of the patient with 44 years of anamnesis of psoriasis 
and no treatment for past six months. On the contrary, 
in patient with 15 years of psoriasis diagnosis finding of 
PGP 9.5 was from few positive structures to moderate 
number. Various earlier studies have investigated the 
role of stress and changes in expression of neuropeptides 
in psoriasis. Recent study by El–Nour et al. (8) suggests 
a down–regulation of innervation during psoriasis 
exacerbation. An unexpected reduction in the number 
of nerve fibers labeled for PGP 9.5 was found in skin 
biopsies from involved skin from psoriasis patients who 
believed that their psoriasis was influenced by stress. No 
association with additional stress was observed in our 
study, thought acquired data propose more profound 
investigation in circumstances of the disease in patient 
with noticeably higher results of PGP 9.5.           
Appearance of MMP2 positive cells in current study 
varied from few positive structures to abundance 
of positive structures in visual field in previously 
mentioned patient with long–drawn progress of the 
disease. In earlier studies higher levels of MMP2 in 
psoriatic lesions as compared to healthy individuals has 
been found in both involved, and uninvolved skin (9).  
Apoptosis was detected by TUNEL method and acquired 
data diversified in very extensive limits. No positive 
staining was detected in two of our cases, material 
of control patient showed few positive structures in 
the visual field, meanwhile also maximal intensity of 
staining could be found in specimens from patients with 
recent onset of psoriasis. Apoptosis has been evaluated 
in accordance with topical vitamin D analogue 
calcipotriol therapy after which number of apoptotic 
cells is significantly higher than in non–treated psoriatic 
lesions (7, 21). Biopsies from all patients enrolled in our 
study were taken from places with reduced exposure to 
sun and no previous treatment for at least four weeks 
to exclude such outreach. For all that our broad data 
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suggests that apoptosis expression may also be regulated 
by other factors.           
We discovered pronounced correlation between 
defensin–containing cells and apoptosis findings. 
Considerable increase of defensin–containing cells and 
apoptosis was noticed in sites of active inflammation; 
meanwhile in areas of granulation defensin–containing 
cells and apoptosis findings were negative. Our discovery 
shows firm correlation between expression of defensin–
containing cells, apoptotic cells, and inflammatory 
infiltration in skin of psoriatic lesions. To our knowledge, 
there is no previous data of such revelation. While as 
a control we have examined one healthy skin sample 
which might not be sufficient for strong statistics, our 
material is unique, based on a generally accepted norm 
and gives the first insight in a tendency. Acquired data 
show the complicated nature of skin innate immune 
system. 
As AMPs are of peptide nature, they could present 
such problems as high manufacturing costs, short 
half life, lost of activity in physiological conditions, 
application problems, unwanted systemic reactions, 
and interference with normal flora bacteria when trying 
to use as antimicrobial agents. And also there remain 
unresolved issues to consider: standardized techniques 
to assess the activity, molecular regulation mechanisms, 
the ability to target the site of disease, tolerance and 
toxicity issues, understanding of the role and expression 
of AMPs in health and disease remains a challenging 
area of research (23).     
CONCLUSIONS
Histological findings vary from marked inflammatory 
cell infiltration to granulation tissue and are much 
inwrought with anamnesis of psoriasis:  psoriatic 
lesions of patients with no previous active psoriasis 
treatment feature marked activation of defensin, matrix 
metalloproteinase, apoptosis and neuropeptides–
containing innervation. In skin of psoriasis patients with 
long–term ineffective treatment psoriatic lesion showed 
abundance of positive structures of defensin, matrix 
metalloproteinase and neuropeptides–containing 
innervation. Exception from this should be validated 
as individual variations due to the other unknown 
systemic / local factors affecting tissue changes. Close 
correlation between expression of defensin–containing 
cells, apoptotic cells, and inflammation in the skin was 
found suggesting about possible stimulation of AMPs 
and apoptosis by specific inflammation. 
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Table 1. Relative appearance of defensin, 
neuropeptides–containing innervation and MMP2 





Nr. 1 ++/+++ ++ +
Nr. 2 ++ +/++ ++
Nr. 3 first biopsy +++ +++ +++
Nr. 3 recurrent 
biopsy
+++ +++ +++
Nr. 4 ++++ +/++ ++
Nr. 5 +++ +++ ++
Nr. 6 + +++ +
Nr. 7 ++ ++ ++
Nr. 8 +++/++++ +++/++++ +++/++++
Nr. 9 +++ +/++ +++
Volunteer ++ ++ ++
+ few positive structures in the visual field, 
++ moderate number of positive structures in the visual 
field, 
+++ numerous positive structures in the visual field, 
++++ abundance of positive structures in the visual field.
Table 2. Apoptosis detected with TUNEL 
method in patients with psoriasis
Patient 1 2 3,1 3,2 4 5 6 7 8 9 Volunteer
1. 39.29 46 23.1 52.05 75.32 62.5 0 0 13.46 25.93 20.6
2. 50.8 45.65 13.84 45.71 87.5 65.57 0 0 23.08 24.24 12
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Fig. 1. Marked inflammatory cell infiltration in 
subepithelial layer. Hematoxylin and eosin, X 200
Fig. 2. Diapedesis in blood vessel due to pronounced 
inflammation. Hematoxylin and eosin, X 400
Fig. 3. Sweat gland cell vacuolizati on. Hematoxylin 
and eosin, X 250
Fig. 4. Moderate number of defensin–containing 
cells in volunteer patient’s biopsy material. 
Human beta defensin 2 IMH, X 400
Fig. 5. Marked distribution of defensin in 
subepithelial tissue in psoriatic skin lesion. 
Human beta defensin 2 IMH, X 200
Fig. 6. Abundance of defensin–positive structures 
in the visual field, both epithelial and subepithelial 
tissue in psoriatic skin lesion. Human beta 
defensin 2 IMH, X 200
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Fig. 7. Fine PGP 9.5–containing nerve fibres in 
subepithelium of patient’s skin. PGP 9.5 IMH, 
X 400
Fig. 8. Focal expression of matrix metalloproteinase 
2 positive structures in epithelium and 
subepithelium of patient. MMP 2 IMH, X 200
Fig. 9. Marked apoptosis of epitheliocytes and 
inflammatory cells in patient. TUNEL, X 200
Fig. 10. Marked apoptosis in hair follicle cells of 
patient. TUNEL, X 250
